| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 0.23 | 1.52 | 0.11 | 0.18 |
| Cash Equivalents | 0.12 | 0.07 | 0.00 | 0.03 |
| Long Term Debt | 4.93 | 4.57 | 4.33 | 4.93 |
| Common Stock Total | 10.00 | 10.00 | 10.00 | 10.00 |
| Other Current Assets Total | 0.00 | - | - | - |
| Total Assets | 0.23 | 1.52 | 0.11 | 0.18 |
| Total Equity | -4.73 | -4.44 | -4.30 | -6.32 |
| Retained Earnings( Accumulated Deficit) | -14.73 | -14.44 | -14.30 | -16.32 |
| Total Common Shares Outstanding | 1.00 | 1.00 | 1.00 | 1.00 |
| Tangible Book Valueper Share Common Eq | -4.73 | -4.44 | -4.30 | -6.32 |
| Total Liabilities | 4.95 | 5.95 | 4.42 | 6.50 |
| Total Debt | 4.93 | 4.57 | 4.33 | 4.93 |
| Cashand Short Term Investments | 0.12 | 0.07 | 0.00 | 0.03 |
| Total Receivables Net | 0.00 | 1.34 | - | - |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts Receivable- Trade Net | 0.00 | 1.34 | - | - |
| Total Current Liabilities | 0.02 | 1.39 | 0.09 | 1.58 |
| Accounts Payable | 0.02 | 1.38 | - | - |
| Other Currentliabilities Total | 0.00 | 0.01 | 0.09 | 1.58 |
| Total Long Term Debt | 4.93 | 4.57 | 4.33 | 4.93 |
| Other Long Term Assets Total | 0.11 | 0.11 | 0.11 | 0.11 |
| Note Receivable- Long Term | 0.00 | 0.00 | 0.00 | 0.05 |
| Total Current Assets | 0.12 | 1.41 | 0.00 | 0.03 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Portof LT Debt/ Capital Leases | - | - | 0.00 | 0.00 |
| Cash | - | - | - | 0.00 |
Roselabs Finance Dividend Roselabs Finance Bonus Roselabs Finance News Roselabs Finance AGM Roselabs Finance Rights Roselabs Finance Splits Roselabs Finance Board Meetings Roselabs Finance Key Metrics Roselabs Finance Shareholdings Roselabs Finance Profit Loss Roselabs Finance Cashflow Roselabs Finance Q1 Results Roselabs Finance Q2 Results Roselabs Finance Q3 Results Roselabs Finance Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks